OAC
CNTA

OMERS Administration Corp’s Centessa Pharmaceuticals CNTA Stock Holding History

OMERS Administration Corp’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,500
Closed -$424K – 1110
2025
Q3 		$424K Sell
17,500
-37,700
-68% -$670K ﹤0.01% 783
2025
Q2 		$725K Buy
+55,200
New +$699K 0.01% 578
2025
Q1 		– Sell
-10,200
Closed -$171K – 1049
2024
Q4 		$171K Buy
+10,200
New +$169K ﹤0.01% 886

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

OMERS Administration Corp's CNTA Position: Q4 2025 in Review

OMERS Administration Corp sold out of Centessa Pharmaceuticals (CNTA) in Q4 2025, closing a stake of 17,500 shares — an estimated $424K sold.

OMERS Administration Corp first reported a position in CNTA in Q4 2024 and held it in 3 quarters. The position peaked at $725K in Q2 2025. 146 funds tracked by Wall St. Rank hold CNTA as of Q4 2025.

  • OMERS Administration Corp reported no remaining Centessa Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 17,500 Centessa Pharmaceuticals shares in Q4 2025, an estimated $424K.
  • OMERS Administration Corp first reported a position in Centessa Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • OMERS Administration Corp's Centessa Pharmaceuticals position peaked at $725K in Q2 2025.
  • 146 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.